Navidea Biopharmaceuticals Faces Potential Delisting from NYSE American Exchange
Navidea Biopharmaceuticals (NASDAQ: NAVB) has experienced a significant drop in its shares, with prices falling by 16% to 8 cents. The company has been grappling with the possibility of delisting…